Pathology and diagnosis of renal non-AL amyloidosis

被引:0
|
作者
Sanjeev Sethi
Jason D. Theis
机构
[1] Mayo Clinic,Department of Laboratory Medicine and Pathology
来源
Journal of Nephrology | 2018年 / 31卷
关键词
Amyloid; ALECT2; Apolipoproteins; Fibrinogen alpha; Gelsolin; Laser-microdissection; Mass spectrometry;
D O I
暂无
中图分类号
学科分类号
摘要
Renal amyloidosis is characterized by acellular Congo red positive deposits in the glomeruli, interstitium and/or arteries. Light chain restriction on immunofluorescence studies is present in AL-amyloidosis, the most common type of amyloidosis involving the kidney. The detection of Congo red positive deposits coupled with negative immunofluorescence studies is highly suggestive of non-AL amyloidosis. Some of the non-AL amyloidosis are common while others are relatively rare. The clinical features, laboratory and renal pathology findings are helpful in the diagnosis and typing of non-AL amyloidosis. Thus, ALECT2 amyloidosis is characterized by diffuse cortical interstitial amyloid deposits, AA amyloidosis shows vascular deposits in addition to the glomerular deposits, AFib amyloidosis is characterized by massive amyloid accumulation limited to the glomeruli resulting in the obliteration of glomerular architecture, AApoA1 and AApoAIV are characterized by large amyloid deposits restricted to the medulla, and AGel shows swirling patterns of amyloid fibrils on electron microscopy. While light microscopy is very helpful, accurate typing of non-AL amyloidosis then requires immunohistochemical or laser microdissection/mass spectrometry studies of the Congo red positive deposits. Immunohistochemical studies are available for some of the non-AL amyloidosis. On the other hand, mass spectrometry analysis is a one stop methodology for confirmation and typing of amyloidosis. The diagnosis and typing of amyloidosis by mass spectrometry is based on finding the signature amyloid peptides, apolipoprotein E and serum amyloid-P component, followed by detection of precursor amyloidogenic protein such as LECT2, fibrinogen-α, gelsolin, etc. To, summarize, non-AL amyloidosis is a group of amyloidosis with distinctive clinical, laboratory and renal pathology findings. Typing of the amyloidosis is best performed using mass spectrometry methodology. Accurate typing of non-AL amyloidosis is imperative for correct management, prognosis, and genetic counseling.
引用
收藏
页码:343 / 350
页数:7
相关论文
共 50 条
  • [31] Problems in Diagnosis of NonAA Renal Amyloidosis
    Sen, Sait
    Sarsik, Banu
    Nazan, Ozsan
    Devrim, Bozkurt
    Seckin, Cagirgan
    TURKISH JOURNAL OF PATHOLOGY, 2010, 26 (01) : 14 - 24
  • [32] Renal Amyloidosis: Presentation, Diagnosis, and Management
    Gurung, Reena
    Li, Tingting
    AMERICAN JOURNAL OF MEDICINE, 2022, 135 : S38 - S43
  • [33] Renal amyloidosis: an update on diagnosis and pathogenesis
    Nimisha Gupta
    Harshdeep Kaur
    Saima Wajid
    Protoplasma, 2020, 257 : 1259 - 1276
  • [34] An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis
    Guitard, Joelle
    Guilbeau-Frugier, Celine
    Roussel, Murielle
    Kamar, Nassim
    CLINICAL NEPHROLOGY, 2014, 82 (06) : 392 - 396
  • [35] Renal amyloidosis: an update on diagnosis and pathogenesis
    Gupta, Nimisha
    Kaur, Harshdeep
    Wajid, Saima
    PROTOPLASMA, 2020, 257 (05) : 1259 - 1276
  • [36] AMYLOIDOSIS (AL) - AN APPROACH TO EARLY DIAGNOSIS
    GREIPP, PR
    ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (11) : 2145 - 2146
  • [37] Guidelines on the diagnosis and management of AL amyloidosis
    Bird, J
    Cavenagh, J
    Hawkins, P
    Lachmann, H
    Mehta, A
    Samson, D
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (06) : 681 - 700
  • [38] Guidelines on the diagnosis and investigation of AL amyloidosis
    Gillmore, Julian D.
    Wechalekar, Ashutosh
    Bird, Jenny
    Cavenagh, Jamie
    Hawkins, Stephen
    Kazmi, Majid
    Lachmann, Helen J.
    Hawkins, Philip N.
    Pratt, Guy
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (02) : 207 - 218
  • [39] Updates in the Diagnosis and Management of AL Amyloidosis
    Cook, Joselle
    Muchtar, Eli
    Warsame, Rahma
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (03) : 155 - 167
  • [40] Updates in the Diagnosis and Management of AL Amyloidosis
    Joselle Cook
    Eli Muchtar
    Rahma Warsame
    Current Hematologic Malignancy Reports, 2020, 15 : 155 - 167